Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
182 INR | +12.35% | +14.14% | -3.42% |
Feb. 01 | EP Biocomposites Bags INR49 Million Order for Intermediate Sewerage Pumping Stations, Raising Main | MT |
2023 | EP Biocomposites to Build Sewage Treatment Plant for Oil & Natural Gas Corp. | MT |
Valuation
Fiscal Period: Marzo | 2023 |
---|---|
Capitalization 1 | 338.8 |
Enterprise Value (EV) 1 | 329.7 |
P/E ratio | 51.1 x |
Yield | - |
Capitalization / Revenue | 4.75 x |
EV / Revenue | 4.62 x |
EV / EBITDA | 30,766,283 x |
EV / FCF | 37,423,784 x |
FCF Yield | 0% |
Price to Book | 4.03 x |
Nbr of stocks (in thousands) | 1,682 |
Reference price 2 | 201.5 |
Announcement Date | 8/18/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net sales 1 | 34.1 | 29.48 | 80.6 | 71.31 |
EBITDA | - | 4.601 | 13.83 | 10.72 |
EBIT 1 | 2.592 | 4.598 | 13.17 | 9.721 |
Operating Margin | 7.6% | 15.6% | 16.34% | 13.63% |
Earnings before Tax (EBT) 1 | 2.592 | 4.642 | 11.66 | 8.14 |
Net income 1 | 1.896 | 3.58 | 8.094 | 5.761 |
Net margin | 5.56% | 12.14% | 10.04% | 8.08% |
EPS | - | 9.547 | 9.480 | 3.940 |
Free Cash Flow | - | -0.1752 | -48.59 | 8.81 |
FCF margin | - | -0.59% | -60.28% | 12.36% |
FCF Conversion (EBITDA) | - | - | - | 82.21% |
FCF Conversion (Net income) | - | - | - | 152.93% |
Dividend per Share | - | - | - | - |
Announcement Date | 2/2/22 | 2/2/22 | 8/18/23 | 8/18/23 |
Balance Sheet Analysis
Fiscal Period: Marzo | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net Debt 1 | - | - | 39.6 | - |
Net Cash position 1 | 1.13 | 1.48 | - | 9.1 |
Leverage (Debt/EBITDA) | - | - | 2.86 x | - |
Free Cash Flow | - | -0.18 | -48.6 | 8.81 |
ROE (net income / shareholders' equity) | - | 172% | 67.9% | 11.1% |
ROA (Net income/ Total Assets) | - | 30.6% | 15.5% | 5.79% |
Assets 1 | - | 11.68 | 52.13 | 99.57 |
Book Value Per Share | - | 10.30 | 17.10 | 50.00 |
Cash Flow per Share | - | 3.940 | 1.330 | 13.00 |
Capex | - | 0.03 | 4.74 | 0.22 |
Capex / Sales | - | 0.09% | 5.88% | 0.31% |
Announcement Date | 2/2/22 | 2/2/22 | 8/18/23 | 8/18/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-3.42% | 3.66M | |
+18.48% | 43.41B | |
+7.54% | 32.93B | |
+37.80% | 20.44B | |
-8.50% | 18.64B | |
+5.60% | 15.6B | |
-7.51% | 8.81B | |
-1.50% | 8.86B | |
-8.33% | 7.65B | |
+1.74% | 7.16B |
- Stock Market
- Equities
- 543595 Stock
- Financials EP Biocomposites Limited